• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

¹⁸F-FDG PET/CT 代谢肿瘤体积和总肿瘤糖酵解与子宫内膜癌淋巴结转移及危险分层的预后价值。

Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.

机构信息

Department of Nuclear Medicine, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Department of Radiology, FUWAI Central China Cardiovascular Hospital, Zhengzhou, China.

出版信息

J Gynecol Oncol. 2019 Nov;30(6):e89. doi: 10.3802/jgo.2019.30.e89.

DOI:10.3802/jgo.2019.30.e89
PMID:31576685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6779626/
Abstract

OBJECTIVE

To investigate the prognostic value of metabolic tumor volume (MTV) and total lesion glycolysis (TLG), measured by preoperative ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (¹⁸F-FDG PET/CT), in risk stratification of patients with endometrial carcinoma (EC).

METHODS

The patients with pathological diagnosis of EC who underwent preoperative ¹⁸F-FDG PET/CT imaging were retrospectively selected for analysis of the prognostic values of PET parameters in risk classification and lymph node metastases (LNMs). Receiver-operating-characteristic analysis was used to analyze the correlation of PET parameters cutoff values with deep myometrial invasion (MI), lymphovascular space involvement and LNM for prognostic values in risk stratification.

RESULTS

The sensitivity, specificity, positive predictive value, negative predictive value and accuracy for detection of LNM are 83.3%, 99.7%, 90.9%, 99.5% and 99.2%, respectively. The MTV and TLG of primary lesion of EC in the patients with LNM are notably higher than those in patients without LNM, p<0.010. The MTV and TLG of the EC primary lesions in high-risk patients are significantly higher than those in low-risk patients (p<0.010), but the maximum standardized uptake value (SUVmax) is not. The MTV and TLG of primary lesions were superior to SUVmax for predicting of deep MI, LNM and high-risk of EC (p<0.005).

CONCLUSION

MTV and TLG of primary lesions are more valuable in predicting risk stratification of EC patients. Preoperative ¹⁸F-FDG PET/CT imaging is useful in predicting the LNM of EC and may help guide pelvic lymphadenectomy to avoid unnecessary pelvic lymphadenectomy in EC patients with low-risk stratification.

摘要

目的

探讨术前 ¹⁸F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(¹⁸F-FDG PET/CT)测量的代谢肿瘤体积(MTV)和总肿瘤糖酵解(TLG)在子宫内膜癌(EC)患者风险分层中的预后价值。

方法

回顾性分析经病理诊断为 EC 且行术前 ¹⁸F-FDG PET/CT 成像的患者,分析 PET 参数在风险分类和淋巴结转移(LNM)中的预后价值。采用受试者工作特征分析(ROC)分析 PET 参数截断值与深肌层浸润(MI)、脉管间隙浸润和 LNM 的相关性,以评估其在风险分层中的预后价值。

结果

LNM 检测的灵敏度、特异度、阳性预测值、阴性预测值和准确率分别为 83.3%、99.7%、90.9%、99.5%和 99.2%。LNM 患者 EC 原发灶的 MTV 和 TLG 明显高于无 LNM 患者(p<0.010)。高危患者的 EC 原发灶 MTV 和 TLG 明显高于低危患者(p<0.010),而最大标准化摄取值(SUVmax)则不然。MTV 和 TLG 对预测 EC 深部 MI、LNM 和高危的价值优于 SUVmax(p<0.005)。

结论

原发灶 MTV 和 TLG 对预测 EC 患者的风险分层更有价值。术前 ¹⁸F-FDG PET/CT 成像有助于预测 EC 的 LNM,可能有助于指导盆腔淋巴结清扫术,避免低危分层 EC 患者不必要的盆腔淋巴结清扫术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec8b/6779626/cd2774219c3a/jgo-30-e89-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec8b/6779626/4704ac69f80d/jgo-30-e89-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec8b/6779626/cd2774219c3a/jgo-30-e89-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec8b/6779626/4704ac69f80d/jgo-30-e89-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec8b/6779626/cd2774219c3a/jgo-30-e89-g002.jpg

相似文献

1
Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.¹⁸F-FDG PET/CT 代谢肿瘤体积和总肿瘤糖酵解与子宫内膜癌淋巴结转移及危险分层的预后价值。
J Gynecol Oncol. 2019 Nov;30(6):e89. doi: 10.3802/jgo.2019.30.e89.
2
Retrospective analysis of the F-FDG PET/CT cutoff value for metabolic parameters was performed as a prediction model to evaluate risk factors for endometrial cancer.回顾性分析 F-FDG PET/CT 代谢参数的截断值,作为评估子宫内膜癌危险因素的预测模型。
Radiat Oncol. 2023 Dec 4;18(1):196. doi: 10.1186/s13014-023-02382-6.
3
Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.18F-FDG PET/CT 代谢肿瘤体积有助于术前识别高危型子宫内膜癌患者。
J Nucl Med. 2015 Aug;56(8):1191-8. doi: 10.2967/jnumed.115.159913. Epub 2015 Jun 4.
4
Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.术前 18F-FDG PET/CT 肿瘤标志物预测原发性子宫内膜癌淋巴结转移的效能优于 MRI 标志物。
Eur Radiol. 2020 May;30(5):2443-2453. doi: 10.1007/s00330-019-06622-w. Epub 2020 Feb 7.
5
Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.术前FDG-PET/CT代谢和容积参数对可切除胰腺癌患者的预后价值
Medicine (Baltimore). 2016 May;95(19):e3686. doi: 10.1097/MD.0000000000003686.
6
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.定制高危临床早期子宫内膜癌的系统性淋巴结切除术:18F-FDG PET/CT 的作用。
Gynecol Oncol. 2013 Aug;130(2):306-11. doi: 10.1016/j.ygyno.2013.05.011. Epub 2013 May 23.
7
The correlation of F-FDG PET/CT metabolic parameters, clinicopathological factors, and prognosis in breast cancer.乳腺癌中 F-FDG PET/CT 代谢参数与临床病理因素及预后的相关性。
Clin Transl Oncol. 2021 Mar;23(3):620-627. doi: 10.1007/s12094-020-02457-w. Epub 2020 Jul 18.
8
Prognostic significance of metabolic tumor volume and total lesion glycolysis in patients with advanced cervical carcinoma.代谢肿瘤体积和总病变糖酵解在晚期宫颈癌患者中的预后意义
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019 Jan-Feb;38(1):17-21. doi: 10.1016/j.remn.2018.08.001. Epub 2018 Oct 23.
9
Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer.使用(18)F-FDG PET/CT代谢参数对子宫内膜癌患者进行术前风险分层。
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1268-75. doi: 10.1007/s00259-015-3037-2. Epub 2015 Apr 2.
10
Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.使用术前18F-FDG PET/CT测量的代谢肿瘤体积和总病灶糖酵解可预测子宫内膜癌的复发。
BJOG. 2014 Aug;121(9):1097-106; discussion 1106. doi: 10.1111/1471-0528.12543. Epub 2014 Jan 8.

引用本文的文献

1
Predicting aggressive disease and poor outcome in endometrial cancer using preoperative [F]FDG PET primary tumor radiomics.利用术前[F]FDG PET原发性肿瘤影像组学预测子宫内膜癌的侵袭性疾病和不良预后。
Eur J Nucl Med Mol Imaging. 2025 Jun 11. doi: 10.1007/s00259-025-07335-7.
2
18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature.18F-FDG PET/MRI与18F-FDG PET/CT在妇科恶性肿瘤管理中的应用:文献综述
J Imaging. 2023 Oct 13;9(10):223. doi: 10.3390/jimaging9100223.
3
The Evaluation of Preoperative F-FDG PET/CT in Patients with Endometrial Cancer and the Correlation Between PET Parameters and Postoperative Pathology Results.

本文引用的文献

1
Implications of para-aortic lymph node metastasis in patients with endometrial cancer without pelvic lymph node metastasis.无盆腔淋巴结转移的子宫内膜癌患者腹主动脉旁淋巴结转移的影响
J Gynecol Oncol. 2017 Sep;28(5):e59. doi: 10.3802/jgo.2017.28.e59. Epub 2017 May 22.
2
Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.术前¹⁸F-FDG PET/CT测定的代谢参数对子宫癌肉瘤患者的预后价值
J Gynecol Oncol. 2017 Jul;28(4):e43. doi: 10.3802/jgo.2017.28.e43.
3
The role of para-aortic lymphadenectomy in stage IIIC endometrial cancer: A single-institute study.
子宫内膜癌患者术前F-FDG PET/CT评估及PET参数与术后病理结果的相关性
Mol Imaging Radionucl Ther. 2022 Feb 2;31(1):16-22. doi: 10.4274/mirt.galenos.2021.33154.
4
Application of CT and MRI combined with VEGF-C and EGFR in the identification of endometrial cancer stages.CT与MRI联合VEGF-C和EGFR在子宫内膜癌分期鉴定中的应用
Am J Transl Res. 2021 Jun 15;13(6):7164-7171. eCollection 2021.
5
Positron Emission Tomography for Response Evaluation in Microenvironment-Targeted Anti-Cancer Therapy.正电子发射断层扫描在微环境靶向抗癌治疗中的疗效评估
Biomedicines. 2020 Sep 22;8(9):371. doi: 10.3390/biomedicines8090371.
腹主动脉旁淋巴结切除术在IIIC期子宫内膜癌中的作用:一项单机构研究。
J Obstet Gynaecol. 2017 May;37(4):510-513. doi: 10.1080/01443615.2017.1281894. Epub 2017 Mar 2.
4
Lymphedema after treatment for endometrial cancer - A review of prevalence and risk factors.子宫内膜癌治疗后的淋巴水肿——患病率及危险因素综述
Eur J Obstet Gynecol Reprod Biol. 2017 Apr;211:112-121. doi: 10.1016/j.ejogrb.2017.02.021. Epub 2017 Feb 22.
5
Incidence of Lymph Node Metastasis in Surgically Staged FIGO IA G1/G2 Endometrial Cancer With a Tumor Size of More Than 2 cm.肿瘤大小超过2cm的手术分期为国际妇产科联盟(FIGO)IA期G1/G2子宫内膜癌的淋巴结转移发生率
Int J Gynecol Cancer. 2017 Mar;27(3):486-492. doi: 10.1097/IGC.0000000000000919.
6
Comparison of three surgical approaches for staging lymphadenectomy in high-risk endometrial cancer.高危子宫内膜癌分期淋巴结清扫三种手术入路的比较
Int J Gynaecol Obstet. 2017 Mar;136(3):315-319. doi: 10.1002/ijgo.12073. Epub 2017 Jan 12.
7
Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial.正电子发射断层显像/计算机断层扫描(PET/CT)评估高危子宫内膜癌腹膜后淋巴结转移的效用:美国放射学会影像网络(ACRIN)6671/妇科肿瘤学组(GOG)0233试验结果
Radiology. 2017 May;283(2):450-459. doi: 10.1148/radiol.2016160200. Epub 2017 Jan 3.
8
Prognostic value of volumetric PET parameters in unresectable and metastatic esophageal cancer.容积PET参数在不可切除和转移性食管癌中的预后价值
Eur J Radiol. 2016 Mar;85(3):540-5. doi: 10.1016/j.ejrad.2016.01.002. Epub 2016 Jan 12.
9
The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma.来自(18)F-FDG PET/CT的容积-代谢联合参数可能有助于预测宫颈癌的预后。
Acad Radiol. 2016 May;23(5):605-10. doi: 10.1016/j.acra.2016.01.001. Epub 2016 Feb 4.
10
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.